Decades of incretin therapy data support its use
The weight loss medications we provide at the Institute for Hormonal Balancesemaglutide and tirzepatideare both glucagon-like peptide-1 (GLP-1) receptor agonists, with tirzepatide also being a glucose-dependent insulinotropic polypeptide (GIP) receptor agonist
Crees fifth trial in teens with PCOS and excess weight compared treatment with oral semaglutide, a hormone which stimulates insulin production to reduce blood sugar, against meeting with a dietitian weekly and following a lifestyle food program that reduced simple carbohydrates and fructose
Doctors may recommend more frequent eye exams for glaucoma patients taking semaglutide to ensure that any potential side effects are caught early
Weight Loss Outcomes Associated With Semaglutide Treatment for Patients With Overweight or Obesity, PubMed.gov, Wissam Ghusn, Alan De la Rosa, Daniel Sacoto, Lizeth Cifuentes, Alejandro Campos, Fauzi Feris, Maria Daniela Hurtado, Andres Acosta
.jpg)
